Patients with mild and moderate glaucoma have negative emotions around driving and self-perceived difficulties, according to survey results.
The IOP-lowering technique may disrupt endothelial cells in the corneoscleral trabecular meshwork, a study says.
The topical treatment may be an alternative to F-prostanoid receptor agonists.
An intraocular pressure-lowering goggle system does not affect tonometry readings, a report shows.
Patients who self-identified as having Black race experienced greater intraocular pressure elevation and iritis following the glaucoma procedure than other groups.
Scleral manipulations, concomitant disease linked with events, according to researchers
Microcystic macular edema not associated with faster global visual field decay among patients with primary open-angle glaucoma, according to a study.
An individual with tinnitus is approximately 30% more likely than others to have pre-existing POAG, researchers estimate.
Long-term systemic statin use may reduce glaucoma risk after vitreoretinal surgery, according to a report.
Study shows wedge-shaped microvasculature loss is related to thinner RNFL, disc hemorrhages, VF defects, and larger cup-to-disc ratio.
Glaucoma experts Mildred Olivier, MD, and Ying Han, MD, provide guidance for improving in-office instructions.
Elevating the upper body after descemet membrane endothelial keratoplasty prevents IOP decompensation.
A quarter century-long study shows patients being treated for glaucoma experience visual field loss at rates comparable with healthy individuals.
Cytomegalovirus and Varicella Zoster Virus-Related Uveitic Secondary Glaucoma.
Procedure history, smoking status, laterality, ethnicity, and sex all influence the success of the implants, according to a study.
A patient’s age at the time of operation can influence whether they develop glaucomatous disease later in life.
The dual procedure also cut the need for medication to help manage glaucoma, a report shows.
Study suggests supplementing 24-2 guided progression analysis with OCT imaging and 10-2 visual fields to spot damage from glaucoma.
A year after initial implantation, the shunt resulted in a 79% reduction in need for glaucoma medications, a study shows.
A study examines a functional vision questionnaire among patients with glaucomatous vision impairment.